Balaxi Pharmaceuticals Limited share price
NSE: BALAXI · ISIN INE618N01022
Key numbers
- Market cap
- ₹ 126 Cr
- Current price
- ₹ 22.82
- 52-week high / low
- ₹ 45 / 15
- Stock P/E
- 50.7
- Book value
- ₹ 45.1
- Dividend yield
- 0.00%
- ROCE
- 3.1%
- ROE
- 0.6%
- Debt to equity
- 0.23
- Sales growth (3 yrs)
- -7.1%
- Profit growth (3 yrs)
- -68.6%
- 1-year return
- -51.2%
About Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 71 | 56 | 73 | 71 | 81 |
| Operating profit | 4 | 1 | 3 | 0 | 5 |
| Net profit | 0 | 0 | 0 | 1 | 1 |
| EPS (₹) | 0.05 | 0.04 | 0.06 | 0.11 | 0.24 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.